PRFX
PRF Technologies Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.97
−1.14%Institutional positioning
13F filings over the trailing two quarters
New 4Increased 1Reduced 0Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CITADEL ADVISORS LLC | Increased | 28,575 | Sep 2, 2026 |
| CITADEL ADVISORS LLC | New Position | 13,220 | May 15, 2026 |
| MORGAN STANLEY | New Position | 1,611 | May 15, 2026 |
| UBS GROUP AG | New Position | 869 | May 5, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | New Position | 40 | May 15, 2026 |
| OSAIC HOLDINGS, INC. | Sold Out | 0 | May 15, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 15, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings